Cargando…
Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
Autores principales: | Mammen, Manoj J., Charbek, Edward, Alexander, Paul E., Nici, Linda, Aaron, Shawn D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874415/ https://www.ncbi.nlm.nih.gov/pubmed/33022179 http://dx.doi.org/10.1164/rccm.202009-3605LE |
Ejemplares similares
-
Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details
por: Vozoris, Nicholas T.
Publicado: (2021) -
Reply to Mahler et al.: Pharmacotherapy for Chronic Obstructive Pulmonary Disease: Molecules and Delivery Are Equally Important
por: Nici, Linda, et al.
Publicado: (2020) -
Reply to Prieto-Centurion et al.: Patients with Chronic Obstructive Pulmonary Disease Require More Than Pulmonary Rehabilitation to Improve Outcomes
por: Nici, Linda, et al.
Publicado: (2019) -
Reply to Polverino: Deconvoluting Chronic Obstructive Pulmonary Disease: Are B Cells the Frontrunners?
por: Ladjemi, Maha Zohra, et al.
Publicado: (2019) -
Reply to Mahler: Peak Inspiratory Flow Rate: An Emerging Biomarker in Chronic Obstructive Pulmonary Disease
por: Wu, Ann Chen, et al.
Publicado: (2019)